These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 14454420)
41. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study. Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923 [TBL] [Abstract][Full Text] [Related]
42. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941 [TBL] [Abstract][Full Text] [Related]
43. A case of toxic epidermal necrolysis (Lyell). GILL D Br J Dermatol; 1958; 70(8-9):302-3. PubMed ID: 13572720 [No Abstract] [Full Text] [Related]
44. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction]. Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195 [TBL] [Abstract][Full Text] [Related]
45. [Relationships between Stevens-Johnson syndrome, Lyell's syndrome, dermatitis medicamentosa and exudative erythema multiforme]. Kalamkarian AA Sov Med; 1968 Nov; 31(11):117-23. PubMed ID: 4245770 [No Abstract] [Full Text] [Related]
46. [Muco-cutaneo-ocular syndrome, case of Stevens-Johnson syndrome with grave ocular manifestations]. VENTURI G Boll Ocul; 1952 Jan; 31(1):21-40. PubMed ID: 14925227 [No Abstract] [Full Text] [Related]
47. A systematic review of validated methods for identifying erythema multiforme major/minor/not otherwise specified, Stevens-Johnson Syndrome, or toxic epidermal necrolysis using administrative and claims data. Schneider G; Kachroo S; Jones N; Crean S; Rotella P; Avetisyan R; Reynolds MW Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():236-9. PubMed ID: 22262611 [TBL] [Abstract][Full Text] [Related]
49. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Rzany B; Hering O; Mockenhaupt M; Schröder W; Goerttler E; Ring J; Schöpf E Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350 [TBL] [Abstract][Full Text] [Related]
50. [Stevens-Johnson syndrome with ornithosis contracted by contact in a hospital]. GJERLOW J Nord Med; 1962 Mar; 67():349-51. PubMed ID: 13899046 [No Abstract] [Full Text] [Related]
51. Sifting through the history of the nosology of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis and its clinicopathological relevance. Fernando SL Int J Dermatol; 2021 Jan; 60(1):110-112. PubMed ID: 33252777 [No Abstract] [Full Text] [Related]
52. Toll-like receptor 9 polymorphism in patients with erythema multiforme, Stevens Johnson syndrome and Stevens Johnson syndrome/toxic epidermal necrolysis overlap syndrome. Turan H; Bulbul Baskan E; Yakut T; Karkucak M; Tunali S; Saricaoglu H Bratisl Lek Listy; 2011; 112(5):260-3. PubMed ID: 21682079 [TBL] [Abstract][Full Text] [Related]
53. [Interrelation of erythema multiforme exudativum and Lyell's and Stevens-Johnson syndromes]. Soloshenko EN Vestn Dermatol Venerol; 1981 Jul; (7):30-2. PubMed ID: 7293470 [No Abstract] [Full Text] [Related]
55. A case of contact dermatitis, erythema multiforme, and toxic epidermal necrolysis. Thompson JA; Wansker BA J Am Acad Dermatol; 1981 Dec; 5(6):666-9. PubMed ID: 7320261 [TBL] [Abstract][Full Text] [Related]
59. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)]. Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218 [TBL] [Abstract][Full Text] [Related]
60. A prediction model to identify risk of developing Stevens-Johnson syndrome or toxic epidermal necrolysis in patients with erythema multiforme. Tham LS; Tambyah PA Ann Acad Med Singap; 2003 Sep; 32(5 Suppl):S46-8. PubMed ID: 14968733 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]